美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kalaris Therapeutics Inc.

2.50

-0.0600-2.34%

盘后：2.620.1200+4.80%14:14 EDT

成交量：3.57万

成交额：9.34万

市值：4,675.60万

市盈率：-0.24

高：2.69

开：2.63

低：2.50

收：2.56

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Kalaris Therapeutics Inc.

交易所：

NASDAQ

成立时间：

2019

员工人数：

14

公司地址：

628 Middlefield Road,Palo Alto,California,United States

官网：

http://www.allovir.com

邮编：

94301

电话：

- -

传真：

- -

简介：

Kalaris Therapeutics, Inc.成立于2013年8月16日，是特拉华州的一家有限责任公司。该公司是一家领先的临床晚期细胞治疗公司，开发高度创新的异基因T细胞疗法来治疗和预防毁灭性的病毒性疾病。该公司的创新和专有的病毒特异性T细胞（VST）治疗平台能够产生现成的VST，旨在恢复T细胞缺陷患者的免疫力。

董事

名称

职位

Andrew Oxtoby

President and Chief Executive Officer and Director

David Hallal

Chairman

Anthony Adamis

Director

Leone Patterson

Director

Michael Dybbs

Director

Morana Jovan Embiricos

Director

Napoleone Ferrara

Director

Srinivas Akkaraju

Director

股东

名称

职位

Andrew Oxtoby

President and Chief Executive Officer and Director

Brett Hagen

Chief Accounting Officer

Matthew Feinsod

Chief Medical Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/KLRS/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KLRS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRS\",,,,,undefined,":{"symbol":"KLRS","market":"US","secType":"STK","nameCN":"Kalaris Therapeutics Inc.","latestPrice":2.5,"timestamp":1751562000000,"preClose":2.56,"halted":0,"volume":35701,"hourTrading":{"tag":"盘后","latestPrice":2.62,"preClose":2.5,"latestTime":"14:14 EDT","volume":108,"amount":283.68,"timestamp":1751566479157},"delay":0,"floatShares":4289831,"shares":18702418,"eps":-10.38818,"marketStatus":"美国独立日休市","change":-0.06,"latestTime":"07-03 13:00:00 EDT","open":2.625,"high":2.69,"low":2.5,"amount":93408.0932,"amplitude":0.074219,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.38818,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1751875200000},"marketStatusCode":7,"adr":0,"listingDate":1596081600000,"exchange":"NASDAQ","adjPreClose":2.56,"postHourTrading":{"tag":"盘后","latestPrice":2.62,"preClose":2.5,"latestTime":"14:14 EDT","volume":108,"amount":283.68,"timestamp":1751566479157},"volumeRatio":3.6724192257763844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRS\",,,,,undefined,":{"symbol":"KLRS","floatShares":4289831,"roa":"-681.04%","roe":"--","lyrEps":-10.437743,"volumeRatio":3.6724192257763844,"shares":18702418,"dividePrice":0,"high":2.69,"amplitude":0.074219,"preClose":2.56,"low":2.5,"week52Low":2.28,"pbRate":"0.73","week52High":24.15,"institutionHeld":0,"latestPrice":2.5,"eps":-10.38818,"divideRate":0,"volume":35701,"delay":0,"ttmEps":-10.38818,"open":2.625,"prevYearClose":9.66,"prevWeekClose":2.62,"prevMonthClose":2.67,"prevQuarterClose":2.67,"fiveDayClose":2.56,"twentyDayClose":3.09,"sixtyDayClose":6.6},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1900954228,"yearFounded":2019,"employeeNum":14,"address":"628 Middlefield Road,Palo Alto,California,United States","zipCode":"94301"},"stockCompanyDetail":{"websiteUrl":"http://www.allovir.com","stockEarnings":[{"period":"1week","weight":-0.0234},{"period":"1month","weight":-0.1883},{"period":"3month","weight":-0.6469},{"period":"6month","weight":-0.7606},{"period":"1year","weight":-0.8521},{"period":"ytd","weight":-0.7412}],"compareEarnings":[{"period":"1week","weight":0.022},{"period":"1month","weight":0.0491},{"period":"3month","weight":0.2376},{"period":"6month","weight":0.0564},{"period":"1year","weight":0.134},{"period":"ytd","weight":0.067}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kalaris Therapeutics, Inc.成立于2013年8月16日，是特拉华州的一家有限责任公司。该公司是一家领先的临床晚期细胞治疗公司，开发高度创新的异基因T细胞疗法来治疗和预防毁灭性的病毒性疾病。该公司的创新和专有的病毒特异性T细胞（VST）治疗平台能够产生现成的VST，旨在恢复T细胞缺陷患者的免疫力。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.05141},{"month":2,"riseRate":0.8,"avgChangeRate":0.066777},{"month":3,"riseRate":0.2,"avgChangeRate":-0.236404},{"month":4,"riseRate":0.4,"avgChangeRate":-0.121971},{"month":5,"riseRate":0.2,"avgChangeRate":-0.129753},{"month":6,"riseRate":0.2,"avgChangeRate":-0.073882},{"month":7,"riseRate":0.4,"avgChangeRate":0.014995},{"month":8,"riseRate":0.8,"avgChangeRate":0.189154},{"month":9,"riseRate":0.6,"avgChangeRate":-0.014837},{"month":10,"riseRate":0.2,"avgChangeRate":-0.070906},{"month":11,"riseRate":0.6,"avgChangeRate":0.030408},{"month":12,"riseRate":0,"avgChangeRate":-0.295433}],"exchange":"NASDAQ","name":"Kalaris Therapeutics Inc.","nameEN":"Kalaris Therapeutics Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KLRS\",market:\"US\",,,undefined,":{"directors":[{"name":"Andrew Oxtoby","position":"President and Chief Executive Officer and Director"},{"name":"David Hallal","position":"Chairman"},{"name":"Anthony Adamis","position":"Director"},{"name":"Leone Patterson","position":"Director"},{"name":"Michael Dybbs","position":"Director"},{"name":"Morana Jovan Embiricos","position":"Director"},{"name":"Napoleone Ferrara","position":"Director"},{"name":"Srinivas Akkaraju","position":"Director"}],"executives":[{"name":"Andrew Oxtoby","position":"President and Chief Executive Officer and Director"},{"name":"Brett Hagen","position":"Chief Accounting Officer"},{"name":"Matthew Feinsod","position":"Chief Medical Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLRS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"KLRS","fiscalQuarterEnding":"2025/03","expectedEps":-0.78,"name":null,"time":"盘前","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-2.52},{"market":"US","date":"2025-03-07","symbol":"KLRS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1741323600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-01-16","symbol":"KLRS","defaultRemindTime":1737037800000,"type":"split","dateTimestamp":1737003600000,"forFactor":23,"toFactor":1,"ratio":23},{"market":"US","date":"2024-11-12","symbol":"KLRS","fiscalQuarterEnding":"2024/09","expectedEps":-0.14,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.04},{"market":"US","date":"2024-08-09","symbol":"KLRS","fiscalQuarterEnding":"2024/06","expectedEps":-0.1,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLRS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLRS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":2,"updateTime":1746676800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KLRS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KLRS","date":"2025-07-03","current":-0.615567,"percent":0.956522,"low":-2.839148,"twenty":-1.898714,"median":-0.913935,"eighty":-0.685496,"high":-0.581096,"avg":-1.277409,"sd":0.637949,"marketCap":46756045},"quantilePoints":[{"date":"2025-03-28","current":-2.436259,"twenty":-2.629862,"median":-2.463299,"eighty":-2.415709,"marketCap":168508741},{"date":"2025-04-04","current":-2.000923,"twenty":-2.457891,"median":-2.325397,"eighty":-2.168027,"marketCap":138397856},{"date":"2025-04-11","current":-1.976588,"twenty":-2.405434,"median":-2.167216,"eighty":-1.951712,"marketCap":136714639},{"date":"2025-04-17","current":-1.811647,"twenty":-2.361089,"median":-2.042834,"eighty":-1.880868,"marketCap":125306167},{"date":"2025-04-25","current":-1.762976,"twenty":-2.268073,"median":-1.954956,"eighty":-1.818136,"marketCap":121939732},{"date":"2025-05-02","current":-1.581811,"twenty":-2.177762,"median":-1.903581,"eighty":-1.797045,"marketCap":109409116},{"date":"2025-05-09","current":-1.041021,"twenty":-2.168027,"median":-1.865726,"eighty":-1.715927,"marketCap":72004290},{"date":"2025-05-16","current":-0.871644,"twenty":-2.131794,"median":-1.821111,"eighty":-1.36225,"marketCap":66206559},{"date":"2025-05-23","current":-0.696822,"twenty":-2.051217,"median":-1.811647,"eighty":-0.924751,"marketCap":52927842},{"date":"2025-05-30","current":-0.728832,"twenty":-1.996056,"median":-1.784607,"eighty":-0.873072,"marketCap":55359157},{"date":"2025-06-06","current":-0.765766,"twenty":-1.972262,"median":-1.721064,"eighty":-0.77266,"marketCap":58164519},{"date":"2025-06-13","current":-0.679587,"twenty":-1.946844,"median":-1.576403,"eighty":-0.758379,"marketCap":51618673},{"date":"2025-06-20","current":-0.632803,"twenty":-1.914397,"median":-1.295192,"eighty":-0.733756,"marketCap":48065214},{"date":"2025-06-27","current":-0.630341,"twenty":-1.911693,"median":-0.990998,"eighty":-0.714058,"marketCap":47878190},{"date":"2025-07-03","current":-0.615567,"twenty":-1.898714,"median":-0.913935,"eighty":-0.685496,"marketCap":46756045}],"updateTime":1751634039262}}}